We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Purdue's ‘Duplicative’ Suit Over OxyContin Generic Gets Ax

Law360, Boston (January 16, 2018, 6:29 PM EST) -- Tweaks to a generic opioid’s labeling did not warrant OxyContin maker Purdue Pharma LP to file a separate lawsuit repeating extant patent infringement claims, a federal judge decided in a Boston...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.